Cart
sales@molnova.com
UAMC3203
CAS No. 2271358-64-4
UAMC3203( UAMC 3203 | UAMC-3203 )
Catalog No. M20094 CAS No. 2271358-64-4
UAMC-3203 is a potent and selective Ferroptosis inhibitor (IC50: 12 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 63 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 255 | In Stock |
|
| 100MG | 380 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUAMC3203
-
NoteResearch use only, not for human use.
-
Brief DescriptionUAMC-3203 is a potent and selective Ferroptosis inhibitor (IC50: 12 nM).
-
DescriptionUAMC-3203 is a potent and selective Ferroptosis inhibitor (IC50: 12 nM).
-
In Vitro——
-
In VivoNo toxicity is observed in mice after repeated injections of UAMC-3203 (20 μmol/kg; injected intraperitoneally; daily, over a period of 4 weeks). Animal Model:Wild type mice derived from a Gpx4 fl/fl breeding Dosage:20 μmol/kg Administration:Injected intraperitoneally; daily, over a period of 4 weeks Result:No toxicity was observed.
-
SynonymsUAMC 3203 | UAMC-3203
-
PathwayApoptosis
-
TargetFerroptosis
-
RecptorFerroptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2271358-64-4
-
Formula Weight471.66
-
Molecular FormulaC25H37N5O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:199.3 mM
-
SMILESO=S(=O)(NCCN1CCNCC1)c1ccc(NC2CCCCC2)c(NCc2ccccc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Devisscher L et al. Discovery of Novel Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy. J Med Chem. 2018 Nov 21;61(22):10126-10140.
molnova catalog
related products
-
Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.
-
ROS-generating?agent...
Ros-generating agent 1 has anticancer activity and generates ROS by covalently modifying Sec-498 residues of TrxR.
-
PRLX-93936 HCL
PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
